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Abstract
Lactobacilli are Gram-positive bacteria that are a subdominant element in the human gastrointestinal microbiota, and which
are commonly used in the food industry. Some lactobacilli are considered probiotic, and have been associated with health
benefits. However, there is very little culture-independent information on how consumed probiotic microorganisms might
affect the entire intestinal microbiota. We therefore studied the impact of the administration of Lactobacillus salivarius
UCC118, a microorganism well characterized for its probiotic properties, on the composition of the intestinal microbiota in
two model animals. UCC118 has anti-infective activity due to production of the bacteriocin Abp118, a broad-spectrum class
IIb bacteriocin, which we hypothesized could impact the microbiota. Mice and pigs were administered wild-type (WT) L.
salivarius UCC118 cells, or a mutant lacking bacteriocin production. The microbiota composition was determined by
pyrosequencing of 16S rRNA gene amplicons from faeces. The data show that L. salivarius UCC118 administration had no
significant effect on proportions of major phyla comprising the mouse microbiota, whether the strain was producing
bacteriocin or not. However, L. salivarius UCC118 WT administration led to a significant decrease in Spirochaetes levels, the
third major phylum in the untreated pig microbiota. In both pigs and mice, L. salivarius UCC118 administration had an effect
on Firmicutes genus members. This effect was not observed when the mutant strain was administered, and was thus
associated with bacteriocin production. Surprisingly, in both models, L. salivarius UCC118 administration and production of
Abp118 had an effect on Gram-negative microorganisms, even though Abp118 is normally not active in vitro against this
group of microorganisms. Thus L. salivarius UCC118 administration has a significant but subtle impact on mouse and pig
microbiota, by a mechanism that seems at least partially bacteriocin-dependent.
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Introduction
Lactobacilli are Gram-positive bacteria, commonly associated
with the gastrointestinal tract (GIT) of humans and animals. They
are members of the Lactic Acid Bacteria (LAB) and have a number
of uses in industry especially in the manufacture of dairy products
[1]. Many LAB are considered to have probiotic effects. Probiotics
are defined as ‘‘live microorganisms which when administered in
adequate amounts confer a health benefit on the host’’ [2]. Several
hypotheses have been proposed to explain how these probiotic
microorganisms can be beneficial for the host [3]. Firstly,
probiotics could enhance intestinal barrier function. Madsen and
collaborators showed that the probiotic mixture VSL#3, partially
comprising LAB, improved intestinal epithelial integrity and
reduced its permeability, conferring protection against inflamma-
tory luminal constituents coming from bacteria or diet [4]. They
also showed that probiotic consumption conferred resistance to
Salmonella invasion by reducing intestinal permeability [4].
Secondly, some strains demonstrate immunomodulatory activity.
Indeed, in a recent study, Sierra and collaborators showed that
administration of L. salivarius CECT5713, isolated from breast
milk, improved host immunity by inducing Interleukin (IL)-10 and
some immunoglobulins levels as well as inducing an increase in
Natural Killer cell and monocyte numbers [5]. Furthermore, a
recent study showed that Lactobacillus salivarius B1 can increase the
number of immunocompetent cells and enhance IL-6 gene
expression in the pig intestine [6]. Finally, some probiotic
microorganisms exert protective effects against pathogen invasion
by adhesion or metabolic competition, or inhibition due to
production of antimicrobial compounds. Indeed, some L.
acidophilus and L. rhamnosus strains used as probiotics can prevent
enterohemorrhagic or enteropathogenic Escherichia coli strain
adhesion to epithelial cells and thus reduce infection severity [7].
Moreover, a five-strain probiotic mixture comprising four different
species (and including Lactobacillus salivarius DPC6005) has been
shown to reduce Salmonella carriage in infected pigs [8].
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Whereas recent studies were aimed at elucidating mechanisms
by which probiotics could exert these beneficial effects, few studies
have focused on if and how probiotic administration impacts the
normal microbiota – either directly or indirectly. It is important to
know if these microorganisms could induce alteration of the
composition or activity of the host microbiota, since some
microbial population alterations are associated with intestinal
disorders like obesity or inflammatory bowel disease (IBD) [9,10].
A recent study showed that administration of Lactobacillus
acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07
does not affect major genera in the microbiota of children [11].
However, the specific impact of probiotic consumption on the host
microbiota may depend on the identity and phenotype-specificity
of the strains used. It is thus important to carry out similar studies
using different known probiotic microorganisms, to increase our
knowledge on the impact of probiotics on the normal microbiota,
and to exclude the possibility of undesirable microbiota changes
occurring.
L. salivarius UCC118 is well studied for its probiotic properties.
Corr and collaborators have shown that this strain protects against
Listeria monocytogenes EGDe and LO28 and Salmonella typhimurium
UK1 infections in mice [12]. More specifically, they showed that
the observed anti-Listeria effect was due to production of the
bacteriocin Abp118 [12]. Abp118 is a broad-spectrum class IIb
bacteriocin encoded by an operon located on the L. salivarius
megaplasmid pMP118 [13]. A mutant lacking bacteriocin
production still protected against Salmonella infection whereas it
did not protect against Listeria infection [12]. Thus, the anti-Listeria
effect of UCC118 was due to direct antagonism via Abp118,
whereas its anti-Salmonella effect was more likely due to competitive
exclusion or immunomodulation of host defenses [12]. Because of
the anti-microbial activity associated with Abp118, we hypothe-
sized that administration of L. salivarius UCC118 might impact the
host. The aim of this study was therefore to evaluate the impact of
L. salivarius UCC118 administration and more specifically
bacteriocin production, on the composition of the normal
microbiota of healthy mice and pigs. This was addressed by
determining faecal microbiota composition before and after
treatment, of duration one week and four weeks in mice and pigs
respectively.
Results
Animal model selection and construction of an isogenic
abpT mutant in Lactobacillus salivarius UCC118, deficient
for bacteriocin production
Previous studies have shown that two different strains of L.
salivarius, among them UCC118, exhibited probiotic effects
through anti-infective properties in mice and pigs [8,12,14]. Thus,
these two animal models were selected for the assessment of the
effect of bacteriocin production on host microbiota in these
species.
In the mouse trial, animals were either sterile PBS (control
group), PBS containing L. salivarius UCC118 expressing bacterio-
cin (Bac+ group) or PBS containing L. salivarius UCC118 deficient
for bacteriocin production (Bac2 group). The bacteriocin deficient
mutant had been constructed in a previous study by plasmid
integration into the abpT gene which encodes the bacteriocin
transporter [12] (Table S1). To control for the possible (but
unlikely) effects associated with the integrated plasmid in the
genome of the knock-out strain, the strain producing bacteriocin
and administered to mice in the Bac+ group was a derivative of L.
salivarius UCC118 harboring the same plasmid but integrated in
the non-essential lacZ gene (Table S1). Faeces of each individual of
the three groups were collected at the start of the trial and after 7
days of feeding, and microbiota composition determined by
amplicon pyrosequencing.
For the pig trial, all L. salivarius strains administered were
rifampicin-resistant derivatives of the parent strains. However, the
experimental facility used for the pig trial prohibited the use of
antibiotic-resistant genetically-modified organisms (containing
foreign DNA), and so the strains used for the mouse trial were
not suitable. Thus, a new derivative of L. salivarius UCC118
deficient in bacteriocin production was constructed by clean
deletion of the abpT gene. This isogenic abpT mutant, named L.
salivarius UCC118 DabpT, was constructed using the pORI19/
pVE6007 system previously used in our group to construct an
isogenic sortase mutant in UCC118 [15] (Table S1 and Fig. S1).
In this technique, 1 kb upstream and downstream flanking regions
of the abpT gene were amplified using primers listed in Table S2,
joined by Splicing by Overlap Extension (SOE)-PCR, and then
cloned in the non-replicative pORI19 vector. This construct,
named pORI-DabpT (Table S1), was introduced by transformation
of L. salivarius UCC118 harboring the pVE6007 helper vector to
allow replication of pORI-DabpT. Integration and then excision,
leading to the deletion of the abpT gene, were obtained by the
presence or absence of antibiotic selection pressure (Fig. S1).
Pigs were fed (each day and for 29 days) sterile milk (control
group), milk containing L. salivarius UCC118 WT, producing
bacteriocin (Bac+ group) or milk containing L. salivarius UCC118
DabpT, deficient in bacteriocin production (Bac2 group). Pig
faeces were collected at the start of the trial and after 28 days.
Microbiota composition was determined by pyrosequencing of
16S rRNA gene amplicons. Fecal samples as well as ileal content
and tissue samples were also collected at different times of the trial
and used to enumerate administered strains in the pig GIT.
Finally, pig sera were collected at the start of the trial and after 14
and 29 days of treatment, to evaluate the effect of administering
the respective strains on pig immune system parameters.
Lactobacillus salivarius strain UCC118 survives in the pig
GIT and adheres to the ileal mucosa
Because of their rifampicin resistance, we were able to enumerate
the administered strains in faeces throughout the pig trial and thus
to determine if they were able to survive GIT transit. After 14 days
treatment, all probiotic-fed pigs excreted rifampicin-resistant (RifR)
microorganisms between 2.86103 and 6.16106 CFU/g faeces,
with a median of 5.76104 and 1.76105 CFU/g faeces for the Bac+
group and the Bac2 group, respectively (Fig. 1A). However, a
median of 8.06102 RifR CFU/g faeces was enumerated in control
pig faeces and statistical analysis revealed that control group counts
were not significantly different from counts in Bac+ or Bac2 groups
after multiple testing (p=0.058 and 0.046, respectively; Bonferroni
Correction.0.1) (Fig. 1A). This was due to presence of abundant
naturally RifR microorganisms in two of the control group pigs
which excreted 86106 and 26105 RifR CFU/g faeces, respectively,
whereas the other pigs excreted between 0 and 16103 RifR CFU/g
faeces (Fig. 1A).
Following 28 days treatment, Bac+ and Bac2 groups excreted
RifR microorganisms at median levels of 1.46107 and
3.06108 CFU/g faeces, respectively (Fig. 1B). This was signifi-
cantly higher than similar counts in the control group (9.06102
RifR CFU/g faeces, p,0.001, Bonferroni Correction,0.01)
(Fig. 1B). This shows that L. salivarius UCC118 WT or DabpT
were the major microorganisms responsible for these counts. The
presence of both strains in pig faeces demonstrates that L. salivarius
UCC118 survived transit of the pig GIT. Both strains seemed to
survive similarly as there was no significant difference between L.
L. salivarius Effect on the Intestinal Microbiota
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salivarius UCC118 fecal numbers in the two probiotic-fed groups
(Fig. 1B).
Enumeration of RifR microorganisms was also performed with
ileum tissue and its content after 29 days of treatment. RifR
microorganisms were found in the ileal contents of every pig from
the probiotic-fed groups. All pigs from the Bac+ group, but only 6
of the 8 pigs from the Bac2 group, harbored RifR microorganisms
on the ileal mucosa. A median of 2.76107 and 1.36107 RifR
CFU/g digesta were enumerated in ileal contents from pigs of the
Bac+ and Bac2 groups, respectively (Fig. 2A). These counts were
significantly different from control group counts (2.56101 RifR
CFU/g digesta) and thus associated to L. salivarius UCC118 WT or
DabpT presence in ileal digesta (p,0.005 and Bonferroni
Correction,0.05) (Fig. 2A). Similarly, a median of 2.56101 and
4.96103 RifR CFU/g tissue were enumerated on ileal tissues from
pigs of the Bac+ and Bac2 groups respectively (Fig. 2B). Again,
these counts were significantly different from control group counts
(no RifR CFU for any of the control group pigs) and thus
associated to L. salivarius UCC118 WT or DabpT presence
(p,0.005 and Bonferroni Correction,0.05) (Fig. 2B). This
allowed us to demonstrate that administered strains were able to
survive in, and colonize upon, the ileal mucosa. We also observed
that the mutant strain seemed to colonize slightly better than the
wild-type strain but this difference failed to be significant after
multiple testing (p,0.05 and Bonferroni Correction.0.1) (Fig. 2B).
Lactobacillus salivarius UCC118 administration affects
average daily gain and feed conversion efficiency
parameters in pigs for a small temporal window only
Pigs were individually housed and individual pig weights were
recorded on Day 0. Pig weight and feed removal were recorded
after 14 and 28 days of treatment to allow calculation of average
daily gain, average daily feed intake and feed conversion
efficiency. At the start of the trial, all three groups had similar
pig weight (p.0.10) (Table 1). Similarly, pig weight was similar for
all three treatments at Day 14 (p.0.10) and Day 28 (p.0.10) of
the trial (Table 1). In addition, average daily feed intake of all three
groups was similar at Day 14 (p.0.10) and Day 28 (p.0.10)
(Table 1). However, between Day 14 and Day 28 of the trial,
average daily gain was higher for control pigs than for probiotic-
fed pigs (p=0.006) (Table 1). The lower average daily gain
observed in the probiotic-fed group was associated with a
numerical deterioration in feed conversion efficiency (p=0.06)
compared to the control, during this period. This difference in
average daily gain was not observed between Day 0 and Day 14
Figure 1. L. salivarius UCC118 survives transit of the pig GIT.
Box-plots showing L. salivarius numbers on Day 14 (A) and Day 28 (B) in
fecal samples collected from pigs fed sterile milk (Control group) or milk
incorporating 161010 CFU/day of L. salivarius UCC118 WT (Bac+ group)
or L. salivarius UCC118 DabpT (Bac2 group). Box-plots represent the
median and the lower and upper quartiles. Whiskers extend to the last
data point still within 1.5 inter-quartile range of the quartiles.
doi:10.1371/journal.pone.0031113.g001
Figure 2. L. salivarius UCC118 survives in, and adheres to, the
pig ileum. Box-plots showing L. salivarius numbers on Day 29 in ileal
digesta (A) and tissue (B) samples collected from pigs fed sterile milk
(Control group) or milk incorporating 161010 CFU/day of L. salivarius
UCC118 WT (Bac+ group) or L. salivarius UCC118 DabpT (Bac2 group).
Box-plots represent the median and the lower and upper quartiles.
Whiskers extend to the last data point still within 1.5 inter-quartile
range of the quartiles.
doi:10.1371/journal.pone.0031113.g002
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(p.0.10) or between Day 0 and Day 28 (p.0.10) (Table 1).
However, feed conversion efficiency also tended to be poorer
(p=0.09) for probiotic-fed pigs than the control pigs between Day
0 and Day 28 (Table 1).
We also attempted to measure IL-10 and IL-8 levels in the
treated animals; IL-10 could not be detected by the assay
employed, and there were no statistically significant differences
between IL-8 levels in treatment groups (data not shown).
Mouse and pig microbiota evolved during the time of
the trial
Total DNA was extracted from murine and porcine faeces at
the beginning of the trial and after 7 and 28 days of treatment
respectively, and used to amplify and sequence pooled amplicons
of the V4 (mouse trial) or V4–V5 (pig trial) region of the bacterial
16S rRNA gene. Each sequence read corresponded to a specific
operational taxonomic unit (OTU) and was assigned at the
phylum and genus level by homology comparison. The number of
reads per OTU allowed us to determine the relative abundance of
each OTU.
Principal Coordinates Analysis (PCoA) was used to highlight
similarities or differences between each individual animal on the
basis of their microbiota composition and of the time of sampling
(Day 0 and 7 for the mouse trial and Day 0 and 28 for the pig
trial). This analysis revealed that mice, on Day 0, could not be
discriminated on the basis of microbiota composition as they all
clustered together (cluster 1 =Day 0, Fig. 3). It also allowed us to
show that most individual pigs (19 of 24 pigs) could not be
discriminated on the basis of their microbiota composition
determined on the first day of the trial (cluster 1 =Day 0,
Fig. 4A). However 5 pigs (3 from the control group and 2 from the
Bac2 group) demonstrated a microbiota that was dramatically
different from that of cluster 1 pigs because their microbiota
seemed to be depleted in a number of genera (cluster 3, Fig. 4A).
The two pigs from the Bac2 group had diarrhea on the first day of
the trial. We thus conclude that their abnormal microbiota
composition reflects this condition. The three other pigs from the
control group also demonstrated an abnormal microbiota
composition that was similar to the microbiota of the two pigs
with diarrhea, although these animals did not show any physical
symptoms of disease. Therefore, data from the five pigs with an
abnormal microbiota composition were excluded from further
Day 0 data analysis.
Determination of microbiota composition at the start of the trial
revealed that the mouse microbiota was composed of a majority of
Bacteroidetes and Firmicutes, accounting for almost 95% of total
microbiota (Fig. 5, Table S3). In the pig, these two phyla were also
a majority and represented around 85% of total microbiota.
Comparison of OTU relative abundance between each group
(control, Bac+ and Bac2) confirmed PCoA in showing that there
was no significant difference between the initial microbiota
composition of each group, neither at the phylum nor at the
genus level (data not shown). This is significant because it would
allow us to identify any probiotic-administration related effect on
microbiota composition.
PCoA also revealed that animal microbiota composition
determined at the end of each trial (after 7 days of treatment for
the mouse trial and 28 days for the pig trial) seemed to differ from
the microbiota determined at Day 0 (Cluster 2 =Day 7 and Day
28, Fig. 3 and 4 respectively) with the exception of two mice from
the Bac2 group that tended to cluster with Day 0 mice, on the
basis of their microbiota composition. To evaluate microbiota
evolution over time, and bearing in mind that we had established
that animal microbiota composition was similar at the start of the
trial, we compared relative abundance of all OTUs at the start and
the end of the trial in the control group only. We first observed in
the murine microbiota, small and non significant variations over
time of a number of genera (Table S3). In contrast, one major pig
microbiota phylum significantly increased in proportion during pig
growth. In fact, Spirochaetes proportion represented a median of
Table 1. L. salivarius UCC118 administration effect on pig
growth performance.
Control(a) Bac+(a) Bac2(a)
Weight (kg)
Day 0 12.760.4 12.760.5 12.860.4
Day 14 22.260.7 22.360.8 22.660.7
Day 28 35.160.9 33.660.8 34.460.7
Average daily gain (g)
Day 0–14 675635.5 688627.6 698629.1
Day 14–28 920624.4 848617.9* 807624.4*
Day 0–28 798625.8 748618.2 774616.6
Average daily feed
intake (g)
Day 0–14 747636.9 753628.3 775634.0
Day 14–28 1199628.9 1171645.9 1214632.8
Day 0–28 973630.1 962635.0 995627.1
Feed conversion
efficiency
Day 0–14 1.1160.012 1.1060.013 1.1160.015
Day 14–28 1.3160.029 1.4560.053++ 1.4460.048++
Day 0–28 1.2260.018 1.2960.029+ 1.2960.024+
(a)Values are mean 6 SEM, n= 8.
*p= 0.006,
++p=0.06 and
+p=0.09, between the Bac+ and Bac2 groups and the control group.
doi:10.1371/journal.pone.0031113.t001
Figure 3. Separation of mouse microbiota by treatment group
and time. King plot showing unweighted UniFrac-based PCoA. Each
dot represents an individual at either the start of the trial (Day 0) or after
seven days of treatment (Day 7). Day 0: control group (dark blue), Bac+
group (red), and Bac2 group (purple); Day 7: control group (green),
Bac+ group (light blue), and Bac2 group (yellow).
doi:10.1371/journal.pone.0031113.g003
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0.02 of the microbiota at the start of the trial whereas it
represented a median of 0.15 at the end (p,0.005, Bonferroni
correction,0.05) (Fig. 6A, Table S4). Probably in compensation,
Firmicutes and Bacteroidetes proportions tended to decrease slightly,
but not significantly (Fig. 6A and Table S4). The same variation
was observed at the genus level whereby the proportion of
Treponema, a member of the phylum Spirochaetes, significantly
increased during the time of the trial (median of 0.01 in proportion
at Day 0 compared to a median of 0.15 at Day 28, p,0.005 and
q,0.05) while members of the phylum Firmicutes such as Blautia,
Clostridium, Faecalibacterium, Roseburia or Parasporobacterium signifi-
cantly decreased in proportion (Fig. 6B and Table S4). In addition,
proportions of Butyricimonas and Galbibacter (CFB group bacteria),
Orientia, Sutterella, Desulfovibrio and Actinobacillus (Proteobacteria) and
Methanosphaera (Euryarchaeotes) also changed significantly during the
time course of the trial (Table S4). All these modifications
presumably represent the normal development of the microbiota
during pig or mouse maturation.
Lactobacillus salivarius UCC118 administration induces
modification of the mouse microbiota by a bacteriocin-
dependent mechanism
PCoA revealed a clear separation, at the end of the mouse trial,
between the control and Bac2 groups, and the Bac+ group
(cluster 2A: control and Bac2 groups, Day 7 and cluster 2B: Bac+
group, Day 7; Fig. 3). Comparisons of OTU relative abundance
between each group allowed identification of specific taxa
responsible for this differentiation. In fact, we observed that
proportion of Bacteroidetes decreased whereas Firmicutes increased
more in Bac+ treated mice compared to control and Bac2 treated
mice (Fig. 5A and Table S3). However, changes observed at the
phylum level were not statistically significant after correction for
multiple testing. Similarly, there was no significant difference at
the genus level between microbiota composition of mice of the
control group or of the Bac2 group when compared to all the
other groups. Interestingly, a number of genus proportions were
significantly altered by L. salivarius UCC118 administration when
comparing the microbiota composition of Bac+ group mice to that
of control and Bac2 group mice (Fig. 5B and Table S3). Thus, we
observed a greater decrease in the proportion of Bacteroides
(Bacteroidetes), one of the largest genera in the mouse microbiota,
in Bac+ mice than in other mice (p,0.001, q,0.05) (Fig. 5B and
Table S3). Proportions of two other members of the Bacteroidetes
phylum were affected by L. salivarius UCC118 administration.
Tannerella decreased in Bac+ mice whereas it increased in other
groups and Prevotella showed a greater increase in Bac+ mice than
in other mice (p,0.005, q,0.05 and p,0.0005, q,0.05,
respectively) (Fig. 5B and Table S3). Proportions of four members
of the Firmicutes phylum, Parasporobacterium, Faecalibacterium, Papilli-
bacter and Ethanoligenens were significantly higher in mice from the
Bac+ group than in mice from other groups (p,0.005, q,0.05;
p,0.01, q,0.05; p,0.01, q,0.05 and p,0.005, q,0.05, respec-
tively) (Fig. 5B and Table S3). We conclude from these results that
L. salivarius UCC118 administration affected genera in the
Bacteroidetes and Firmicutes phyla. As these effects were only
observed when the wild-type strain was administered, we can
say that bacteriocin production was mainly responsible for L.
salivarius UCC118 administration effects on mouse microbiota.
Lactobacillus salivarius UCC118 administration induced
modification of the pig microbiota which was greater
with a bacteriocin producing strain
PCoA analysis showed that the microbiota composition of
probiotic-fed pigs tended to cluster together and tended to differ
from control pigs (cluster 2A: control group, Day 28 and cluster
2B: Bac+ and Bac2 groups, Day 28; Fig. 4B). One pig from the
Bac2 group, at Day 28, did not cluster with any of the other pigs
for yet unknown reasons and was considered as an outlier; data
from this pig were excluded from further analyses. Comparison of
OTU relative abundance between each group allowed identifica-
tion of specific taxa responsible for differentiation between groups.
Thus, we observed that the proportion of Spirochaetes, one of the
largest phyla in the pig microbiota, was measurably affected by L.
salivarius UCC118 administration. Whereas, as already stated,
Spirochaetes proportion significantly increased over time in control
pig microbiota, its proportion remained constant in Bac+ pig
microbiota (Fig. 6A and Table S4). Thus, the proportion of
Spirochaetes was significantly lower in Bac+ pig microbiota than in
Figure 4. Separation of porcine microbiota by treatment group and time. King plots showing PCoAs based on (A) unweighted UniFrac data
and (B) weighted UniFrac data. Each dot represents an individual at either the start of the trial (Day 0) or after 28 days of treatment (Day 28). Day 0:
control group (orange), UCC118 Bac+ group (purple), UCC118 Bac2 group (red) and Day 28: control group (green), UCC118 Bac+ group (yellow),
UCC118 Bac2 group (blue).
doi:10.1371/journal.pone.0031113.g004
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control pig microbiota after 28 days treatment (p,0.005, Bonferroni
correction,0.05) (Fig. 6A and Table S4). In the Bac2 group, we
observed an intermediate state: the proportion of Spirochaetes tended
to increase but to a lesser extent to what occurred in the control
group (Fig. 6A and Table S4). After statistical analysis, Spirochaetes
proportion in the Bac2 pig microbiota was significantly lower
compared to that in control pig microbiota when only considering p
value, but it did not reach significance after adjustment for multiple
testing (p,0.05, Bonferroni correction.0.5). Moreover, Spirochaetes
proportion in Bac2 pig microbiota was not significantly different
from the proportion observed in Bac+ pig microbiota. We observed
the same phenomenon at the genus level, where the trend for
Treponema (Spirochaetes) evolved in the same way as the whole phylum
did (Fig. 6B and Table S4). Treponema proportion was thus
significantly lower in microbiota of the Bac+ pigs than in the control
pigs (p,0.005, q,0.05). The Treponema proportion of the Bac2 pig
microbiota was lower compared to the proportion of Treponema in
control pigs (p,0.05) but this difference was not significant after
multiple testing (q.0.1). Moreover, Treponema proportion in Bac2
treated pig microbiota was not significantly different from proportion
observed in the Bac+ group. A number of Firmicutes genera were also
affected by L. salivarius UCC118 administration during the pig trial.
Thus, we observed that whereas the proportion of Sudboligranulum
increased in all three groups during the trial, a significantly greater
increase occurred in the Bac+ group compared to the control group
(p,0.005, q,0.05) (Table S4). While the proportion of Oribacterium
decreased in the control group over time, it increased in both
probiotic-fed pig groups, but this difference was only significant
when comparing Bac+ and control groups (p,0.005, q,0.05) (Table
S4). Anaerostipes proportion tended to slightly increase over time in the
control group whereas it decreased in both the Bac+ and Bac2
groups. Thus, proportion of Anaerostipes was significantly lower in the
Bac+ group than in the control group (p,0.005, q,0.05). Proportion
of Anaerostipes in the Bac2 group was not statistically different from
levels observed in the two other groups (Table S4). Lactonifactor
proportion decreased with time in the three groups but the decrease
was significantly higher in Bac+ group (p,0.005, q,0.05) (Table S4).
Finally, the proportion of Hallella (Bacteroidetes) decreased in the
control group whereas it tended to remain constant over the time in
both Bac+ and Bac2 groups (Table S4). TheHallella proportion was
thus significantly higher in the Bac+ group compared to the control
group (p,0.01, q,0.05) whereas it was not different from Hallella
Figure 5. Microbiota composition in mice. Graphs represent the microbiota composition at the phylum (A) or genus (B) level in mice at the start
of the trial (Day 0) and after 7 days of treatment (Day 7). Values represent the median proportions of classified reads for each phylum or genus as
determined by the RDP classifier and for each treatment group: Control Bac+ and Bac2.
doi:10.1371/journal.pone.0031113.g005
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proportion in the Bac2 group. We can conclude from these results
that administration of L. salivariusUCC118WT significantly affected
pig microbiota leading to significant differences between microbiota
composition of control and Bac+ groups. We observed that
administration of the mutant strain, L. salivarius UCC118 DabpT,
led to an intermediate state: the porcine fecal microbiota
composition in this group was not statistically different from either
of the other two groups, but tended to be more similar to the
microbiota recorded for the Bac+ group. This result concurs with
PCoA which showed that Bac+ and Bac2 pigs tend to cluster
together and tend to differ from control pigs (Fig. 4B). We can thus
say that bacteriocin production may be only partially responsible for
the L. salivariusUCC118 administration effects on the pig microbiota.
Other mechanisms could be involved and need to be identified.
Administration of probiotic L. salivarius UCC118 did not
significantly alter intestinal microbiota diversity in mice
or pigs
To measure global effects upon microbiota composition
wrought by L. salivarius UCC118 administration, we calculated
the Shannon Index and Phylogenetic Diversity for the control and
treatment groups pre- and post-administration (Figure S2). In the
mouse trial, the Phylogenetic Diversity, but not the Shannon
Index, increased over the 7 days of the intervention. There was no
significant difference within or between any of the groups at either
time point (Fig. S2A; Results not shown for between-group
analysis). The bar chart of the data gives the impression that some
of the comparisons, particularly within the Bac2 and Bac+, would
have significant p-values, but the small sample sizes and large
variation within the samples lead to non-significance.
In the pig trial, the alpha diversity in the control group at four
weeks was significantly different from alpha diversity at one week
for both Shannon diversity and Phylogenetic Diversity (Fig. S2B).
The Bac2 group showed a significant difference in Phylogenetic
Diversity only, but neither measure of alpha diversity was
significantly different between Day 0 and Day 28 in the Bac+
group (Fig. S2B). There were no significant differences between
any of the groups at either time point (Results not shown).
Because of slightly longer average read lengths, we were able to
identify some dominant lactobacilli in the murine faecal samples,
but not the porcine samples. The predominant Lactobacillus species
(among those identifiable) were L. aviarius, L. equicursoris, L.
intestinalis, L. salivarius, and L._vitulinus, with L. intestinalis being
numerically most abundant. However, the Kruskal-Wallis test
Figure 6. Microbiota composition in pigs. Graphs represent the microbiota composition at the phylum (A) or genus (B) level in pigs at the start
of the trial (Day 0) and after 28 days of treatment (Day 28). Values represent the median proportions of classified reads for each phylum or genus as
determined by the RDP classifier and for each treatment group: Control Bac+ and Bac2.
doi:10.1371/journal.pone.0031113.g006
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showed a p-value of 0.21 (Kruskal-Wallis chi-squared = 7.13,
df = 5), which shows that there is no difference in the number of L.
intestinalis between any pair of groups in the dataset.
Discussion
The aim of this study was to assess the effect of the
administration of L. salivarius UCC118 and more specifically the
effect of bacteriocin production by this microorganism on the
intestinal microbiota of mammalian models, using faeces as a
surrogate. For simplicity, we determined microbiota composition
pre- and post-intervention periods of one and four weeks in mice
and pigs, respectively. Shorter duration microbiota perturbations
may have been overlooked by this pragmatic trial design. Overall,
two measures of microbiota diversity, Shannon index and
Phylogenetic Diversity, did not alter significantly within or
between treatment groups, but as noted above, large inter-
individual variation within treatment groups may confound this
measurement.
Our observation that L. salivarius UCC118 survived pig
gastrointestinal tract and colonized the pig ileum, is concordant
with the behavior of another L. salivarius strain, DPC6005 [14,16].
Moreover, Walsh and collaborators showed that among a five
strain probiotic mixture, L. salivarius DPC6005 was predominantly
recovered from ileal digesta and mucosa compared to the 4 other
Lactobacillus species used in the mixture [14]. The authors
hypothesized that this was due to a competitive advantage
afforded by Salivaricin P produced by L. salivarius DPC6005
[14]. The bacteriocin Abp118 produced by L. salivarius UCC118,
is highly similar to Salivaricin P [17] and we thus hypothesized
that its production would also confer an advantage to L. salivarius
UCC118 intestinal colonization. However, our data do not
provide a straightforward confirmation of this hypothesis. Indeed,
we observed no significant difference between the colonizing
ability of L. salivarius UCC118 WT and its non-bacteriocin-
producing derivative in pigs. On the contrary, L. salivarius
UCC118 DabpT tended to be present in higher numbers on
porcine ileal mucosa than the wild-type strain. It thus seems that
under the conditions employed, L. salivarius UCC118 ileal
colonization was not due to bacteriocin production. It should be
noted that in our study, L. salivarius UCC118 was administered
alone and not as a member of a probiotic mixture. It thus did not
need to compete with other members of the inoculum as in the
study of Walsh and collaborators [14]. So, it can be hypothesized
that the apparent predominance of L. salivarius DPC6005 in the
porcine ileal mucosa was not due to competition with member(s) of
the host microbiota, but was due to competition with the other
components of the probiotic mixture. However, as molecular
methods could not be applied in this study, we assed the number of
administered probiotics by bacterial cell enumeration. This
technique may not be the most accurate but gives a good overview
of the capacity of the probiotic strain to survive and colonize
within the GIT.
We also showed in this study that between Day 14 and Day 28
of the trial, pigs fed probiotics gained significantly less weight than
pigs in the control group. This was associated with higher feed
conversion efficiency during this period, for these groups
compared to the control group. This result contradicts the finding
of a previous study that found that administration of Lactobacillus
reuteri BSA131 to piglets enhanced pig daily weight gain and feed
conversion rate [18]. However, our results are in accordance with
a recent study showing that intake of Lactobacillus gasseri SBT2055
by adults with obese tendencies significantly reduced body weight
and body fat mass among other parameters [19]. We can conclude
that the probiotic effect on body weight is species and strain
dependent. While body weight enhancement can be useful in
animal production, the opposite effect would be very useful for
human weight management. Further studies including measure-
ment of probiotic effect on other host factors like adiponectin or
calprotectin are needed to confirm this possibility.
Many lactobacilli have been shown to modulate host immunity
[5,6,14]. We attempted to measure porcine IL-10 levels but
despite several attempts to improve the protocol, we were not able
to detect IL-10 in pig serum. L. salivarius UCC118 consumption
had no effect on IL-8 levels in pig. We cannot exclude the
possibility that production of other cytokines such as IL-12 or IL-6
might be modulated by UCC118, as shown for other L. salivarius
strains [6,20].
Microbiota composition of control animals revealed that the
major phyla in pigs were (in decreasing order of importance):
Firmicutes, Bacteroidetes, Spirochaetes and Proteobacteria. These results
are in accordance with a previous study carried on by Lamendella
and collaborators [21] where they showed that the most abundant
phyla in pigs are Firmicutes and then Bacteroidetes. According to this
study, two other phyla are also present in great amount in pigs:
Proteobacteria and Spirochaetes. Similarly, in the mouse trial, we
determined that the major microbiota phyla were (in decreasing
order of importance): Bacteroidetes, Firmicutes, Tenericute, Proteobacteria
and TM7. These results are in accordance with results of a
previous study where the authors showed that the relative
abundances of the major phyla were: Firmicutes 30–70%;
Bacteroidetes, 10–40%; Proteobacteria 1–15%; Actinobacteria, Tenericutes,
TM7, and Verrucomicrobia 0.1–0.5% [22].
The design of these studies allowed us to determine what
microbiota alterations were due to probiotic administration, or to
bacteriocin production. Despite administration of a large inocu-
lum of L. salivarius UCC118 to animals (around 161010 CFU/
day), total proportions of Lactobacillus in microbiota of probiotic fed
animals did not change over the time course of the trials. We can
hypothesize that L. salivarius UCC118 replaced other members of
the Lactobacillus genus. In mice and pigs, members of the phylum
Firmicutes were affected either positively or negatively by L. salivarius
UCC118 consumption. In both trials, this effect was observed
when the wild-type cells were administered, allowing us to
conclude that this effect is bacteriocin dependent. Reduction in
proportion of certain Firmicutes genera was foreseen, as Abp118 is
active on closely related microorganisms i.e. Firmicutes members
[23]. If some bacteriocin-sensitive Firmicutes members decrease in
proportion, others will have the opportunity to replace them,
explaining our observation that some Firmicutes members increased
in proportion. Elimination-succession could be a general phenom-
enon related to bacteriocin action upon microbiota composition.
Probiotic consumption also affected Gram negative microor-
ganisms in both mouse and pig models. This is a surprising and
interesting result because, as stated above, Abp118 has been
shown in vitro to be active only against closely related species, and
bacteriocins elaborated by LAB are normally active exclusively
against Gram positive microorganisms [23,24,25]. Moreover,
Corr and collaborators showed that Abp118 is not active against
Salmonella typhimurium, and hypothesized that the L. salivarius
UCC118 protective effect against this pathogen is more likely
due to competitive exclusion or immunomodulation of host
defenses [12]. However, LAB bacteriocin activity against Gram
negative microorganisms can be detected under certain in vitro
conditions e.g. when the outer membrane is permeabilized as
when EDTA treated [24,26]. Moreover, a novel bacteriocin
produced by L. salivarius 1077 was identified in a recent study and
demonstrated activity against a number of Gram negative genera
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such as Salmonella and Campylobacter, both in vitro and in vivo [27].
The reductions we observed in proportions of Bacteroides and
Tanerella (Bacteroidetes) in mice administered L. salivarius UCC118
WT when compared to the control, might exemplify anti-Gram
negative bacterium activity of LAB bacteriocins under in vivo
conditions. We also showed that Treponema (Spirochaetes) propor-
tions were significantly lower in pigs fed L. salivarius UCC118
WT, when compared to the control. However, Treponema levels
also tended to be lower in pigs fed bacteriocin deficient L.
salivarius UCC118 cells, demonstrating that bacteriocin produc-
tion may not be entirely responsible for the observed effect. In
this context, it is interesting to note that a recent metagenomic
study identified unusually high levels of certain Spirochaetes in the
porcine gut, relative to other mammals [21]. Thus the ability of
L. salivarius to modulate these levels could be significant. In
addition to bacteriocin production, other yet-unknown bacterial
properties such as competition for intestinal niches (competitive
exclusion), may also be involved in Spirochaetes inhibition by L.
salivarius. It should be noted that the Gram negative genera
Prevotella, in mouse, and Hallella, in pig, showed greater
proportions in the Bac+ treated group compared to the control
group. This effect can be explained, as for Firmicutes, by the fact
that if some genera tend to decrease, other can thus replace the
former and expand in proportion. The biological significance of
alterations caused upon levels of gram-negative bacteria is
currently unclear, but could be significant. For example, Prevotella
can cause opportunistic infection in humans and some Tannerella
strains can act as anaerobic periodontal pathogens [28,29]. As
noted above, Gram-negative bacteria are typically insensitive in
vitro to bacteriocins from gram positive bacteria because of
exclusion by the outer membrane; this exclusion may be less
effective in vivo, for example by chelation of divalent cations that
stabilize this outer membrane. Further research is required to
determine precisely how L. salivarius UCC118 can induce
inhibition of certain Gram negative microorganisms.
L. salivarius UCC118 modulation of Gram negative bacterium
proportions is interesting because it supports the concept of a
counter-pathogen effect by a probiotic. Bacteroidetes and Spirochaetes
include natural members of the intestinal microbiota that, under
certain conditions, can become opportunistic pathogens in both
humans and animals. Treponema sp. has been shown to induce
colitis, and Bacteroides sp. synthesizes a toxin that can lead to
diarrhea in the infected host [30,31]. Administration of cultures
like L. salivarius UCC118 could afford animals some degree of
protection from these kinds of infections. It is also noteworthy that
microbiota alterations linked to L. salivarius UCC118 administra-
tion were limited to a small number of genera and are clearly less
dramatic than microbiota disruption caused by antibiotic
treatment [32,33]. The fact that L. salivarius UCC118 did not
cause dramatic alteration in the fecal microbiota is also reassuring,
as the consumption of probiotic products should not lead to
potentially drastic microbiota re-modeling. Such a conclusion
cannot be generalized, however, and will be qualified in future
studies by reference to strain identity, by dosage, and by sampling
the microbiota throughout the GIT length, rather than just in
faeces.
Materials and Methods
Ethics Statement
Experiments with mice were approved by the UCC Animal
Experimentation Ethics Committee and experimental procedures
were conducted under license from the Irish Government (license
number B100/3729).
The pig experiments described below complied with European
Union Council Directive 91/630/EEC (outlines minimum
standards for the protection of pigs) and European Union Council
Directives 98/58/EC (concerns the protection of animals kept for
farming purposes) and was approved by, and a license obtained
from, the Irish Department of Health and Children (license
number B100/4147).
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are listed
in Table S1. Lactobacillus salivarius strain UCC118 and its
derivatives were grown at 37uC under microaerophilic conditions
(5% CO2) in de Man-Rogosa-Sharpe (MRS) medium [34]
(Oxoid Ltd., Basingstoke, Hampshire, United Kingdom). When
required, erythromycin (4 mg/ml), chloramphenicol (4 mg/ml), or
rifampicin (150 mg/ml) were added to the culture media.
Escherichia coli EC101 and Lactococcus lactis LL108 were used in
this study as plasmid hosts. E. coli EC101 was cultured under
vigorous shaking at 37uC in LB medium [35] (Oxoid Ltd.,
Basingstoke, Hampshire, United Kingdom) with kanamycin
(25 mg/ml) and erythromycin (300 mg/ml) when required. L.
lactis LL108 was cultured without shaking at 30uC in M17
medium containing 0.5% glucose [36] (Oxoid Ltd., Basingstoke,
Hampshire, United Kingdom) with erythromycin (5 mg/ml) when
required.
DNA manipulations
The primers used in this study were purchased from MWG
Biotech (Ebersberg, Germany) and are listed in Table S2. For
cloning purposes, Pwo DNA Polymerase (Roche, Mannheim,
Germany) was used for PCR amplification, while for screening
purposes BIOTAQ DNA Polymerase (Bioline, London, United
Kingdom) was used. Restriction endonucleases, T4 DNA ligase,
and PCR purification kits were purchased from Roche and used
according to the manufacturer’s recommendations. E. coli
EC101 and L. lactis LL108 were used as hosts for pORI19
constructs. Plasmid DNA was isolated from E. coli and L. lactis by
using the QIAprep spin Miniprep kit (QIAGEN, Crawley,
United Kingdom) adapted for use with lactococci by the
incorporation of 20 mg/ml lysozyme (Sigma, St. Louis, MO)
in the first buffer. Genomic DNA of L. salivarius UCC118 was
isolated as previously described [23]. L. salivarius UCC118 was
transformed by using a procedure described by van Pijkeren
et al. [15].
Creation of an abpT deletion mutant
The different steps involved in the creation of the mutant and
the verification of the clean deletion are presented in Figure S1.
Genomic DNA of L. salivarius UCC118 was used as a template for
PCR amplification of the 59- and 39-end-flanking regions of the
abpT gene (LSL_1910), using primer pairs abpT-US for/abpT-US rev
and abpT-DS for/abpT-DS rev (Table S2). The amplicons were
joined by SOE-PCR using the primer pair abpT-US for/abpT-DS
rev (Table S2). The resultant 2 kb amplicon was digested using
BamHI and EcoRI and cloned into pORI19 digested with the same
enzymes. The resultant plasmid was named pORI-DabpT (Table
S1 and Figure S1A). The abpT clean deletion mutant in L. salivarius
UCC118 was constructed as described previously [15]. Deletion of
the abpT gene was further confirmed by PCR amplification using
the primer pair abpT KO for/abpT KO rev, which flanks the abpT
gene (Table S2) and by Southern hybridization (Fig. S1B).
Absence of bacteriocin production was confirmed as previously
described [12] (Fig. S1C).
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Mouse feeding trial
15 Female Balb/c mice aged 8–10 weeks were used for the
mouse trial. During the treatment period, in addition to a standard
rodent diet, each mice in the probiotic groups were administered
161010 CFU of L. salivarius UCC118 lacZ (Bac+ group) or L.
salivarius UCC118 abpT (Bac2 group) (Table S1) in 0.1 ml PBS by
oral gavage daily for 7 days as was done by Bernbom and
collaborators [37]. A control group of mice was fed sterile PBS
(Gibco, Paisley, Scotland) daily for 7 days, in addition to a
standard rodent diet. At all times during the trial, mice were
provided with ad libitum access to fresh water. Five mice were used
per group. Administered cultures were prepared as follows: every
day and for each of the probiotic groups, 100 ml MRS was
inoculated with either the wild type or mutant probiotic strains
and these cultures were incubated overnight at 37uC (5% CO2).
Cells were harvested, washed twice in PBS and diluted in 1 ml
PBS in order to obtain 161011 CFU/ml. 0.1 ml aliquots of the
appropriately prepared cultures were administered to mice daily.
On the first and last day of the feeding trial (Day 0 and Day 7),
fecal samples were collected in sterile containers. They were stored
at 4uC until DNA extraction was performed (on the day of
collection). All mice except 2 gave a fecal sample on the first day of
the trial. The two mice belonged to the Bac2 group and
consequently pyrosequencing analysis was carried out on 3
samples instead of 5 in this group (Day 0, control group: n=5,
Bac+: n=5 and Bac2: n=3). At the end of the trial, we were able
to collect samples from all mice (Day 7, control group: n=5, Bac+:
n=5, Bac2: n=5).
Pig feeding trial
A total of 30 crossbred (Large White6Landrace) pigs (entire
males) were weaned at c. 26 days of age. For the first 7 days post-
weaning, pigs were fed an un-medicated starter diet (16.33 MJ
digestible energy/kg and 15.5 g/kg lysine). This was followed by a
7-day acclimatization period, during which 100 ml of sterile
reconstituted skim milk (RSM) was fed daily to each pig in
addition to an un-medicated basal diet, which was formulated to
contain 15.38 MJ digestible energy /kg and 14.7 g/kg total lysine.
At 14 days post-weaning (Day 0), pigs were blocked by weight and
ancestry. Within blocks, 24 pigs were randomly assigned to one of
three treatment groups (control Bac+ or Bac2 groups, each
containing eight pigs) for the 29-day treatment period (day 0–29).
Pigs were individually penned and each treatment group was
housed in separate but identical rooms to prevent cross-
contamination between groups. During the treatment period, in
addition to the basal diet, each pig in the probiotic groups received
100 ml RSM containing 161010 CFU of L. salivarius UCC118
WT Rif (Bac+ group) or L. salivarius UCC118 Dabpt Rif (Bac2
group) (Table S1) daily, while pigs in the control group received
100 ml sterile RSM daily as well as basal diet as was done by
Casey et al. and Gardiner et al. [8,16]. At all times during the trial,
pigs were provided with ad libitum access to fresh water and the
basal diet. Administered cultures were prepared as follows: for
each of the probiotic groups, 700 ml MRS broth was inoculated
with one of the probiotic strain to be administered (1% inoculum)
and incubated overnight at 37uC (5% CO2). Cells were harvested,
washed twice in PBS and diluted in 7 litters of RSM in order to
obtain 16108 CFU/ml. 100 ml aliquots of probiotic milk were
stored at 4uC for no longer than 7 days before being administered
to pigs.
On the first, 14th and 28th days of the feeding trial (Day 0, Day
14 and Day 28), following rectal stimulation, fecal samples were
collected into sterile containers from each of the pigs. They were
stored at 4uC until microbiological analysis was performed or
280uC for no more than two days until microbiota analysis was
performed. Fecal samples were collected from all pigs but one on
Day 0 and from all pigs on Day 28. A fecal sample was collected
on Day 2, for the pig (Control group) that was not sampled on Day
0. On Day 29, all the pigs were slaughtered by captive bolt
stunning followed by exsanguination and the entire GIT was
removed. Immediately, 30 cm before the ileo–cecal junction, both
ileal digesta and tissues were sampled for microbiological analysis.
These samples were placed on ice for transport to the laboratory
where they were stored at 4uC until microbiological analysis was
performed (on the day of collection).
Microbiological analysis of pig fecal and ileal samples
As L. salivarius is a natural inhabitant of the GIT, it is not
possible here to differ between natural and administered L.
salivarius and it is thus impossible to use molecular methods to
assess the quantity of administered L. salivarius strains which have
survive and/or colonize within the GIT. Thus, to allow
enumeration of the probiotic strains used in this study,
rifampicin-resistant variants of L. salivarius UCC118 WT and
DabpT, named L. salivarius UCC118 WT Rif and UCC118 DabpT
Rif (Table S1), were generated by selection on MRS agar plates
supplemented with increasing concentration of rifampicin (5 to
150 mg/ml). Probiotic counts were obtained by homogenization of
1 g of fecal or ileal digesta samples in maximum recovery diluent
(MRD; Bectin Dickinson, Franklin Lakes, NJ), followed by 10-fold
dilutions in MRD and spread-plating on Lactobacillus selective agar
(LBS; Becton Dickinson, Cockeysville, MD) supplemented with
150 mg/ml rifampicin as a selective agent and 50 U/ml nystatin
(Sigma-Aldrich, St Louis, MO) to inhibit yeasts and moulds. Ileal
tissue samples were rinsed gently in MRD to remove digesta and
were further washed by immersing in MRD and shaking
vigorously for 5 min. Tissue samples (1 g) were then homogenized
in fresh MRD as 10-fold dilutions using a stomacher (Seward,
London, UK). The resulting homogenate was further diluted 10-
fold in MRD and appropriate dilutions were spread-plated on LBS
supplemented with 150 mg/ml rifampin and 50 U/ml nystatin.
These plates were incubated anaerobically at 37uC for 2 days.
Determination of cytokine levels by ELISA experiments
Whole blood samples were taken from the anterior vena cava of
each pig and collected in serum (Silicone-Coated Interior)
collection tubes (BD Vacutainer Systems, Franklin Lakes, NJ) on
days 0, 14 and 29. Samples were stored at room temperature for at
least one hour. The serum fraction of each sample was then
isolated by centrifugation and stored at 280uC until further use.
Concentrations of IL-8 and IL-10 were determined in these
fractions using porcine-specific cytokine ELISA kits (R&D
Systems, Minneapolis, MN) in accordance with the manufacturer’s
instructions.
Microbiota analysis
DNA was extracted from fecal samples using the QIAamp DNA
Stool Mini Kit, according to standard protocol (Qiagen, West
Sussex, UK). The V4 or V4–V5 regions of the 16S rRNA gene
were amplified as described by Claesson and collaborators with
small modifications in PCR conditions [38]. A single separate
PCR was performed on each sample using universal 16S rRNA
primers, listed in Table S2, and BIOTAQ DNA Polymerase,
according to the manufacturer’s recommendations (Bioline,
London, United Kingdom). The PCR conditions were 94uC for
50 seconds (initialization and denaturing), 42uC for 30 seconds
(annealing), 72uC for 60 seconds in 35 cycles (extension), and a
final elongation step at 72uC for 5 minutes. Negative control
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reactions containing all components, but water instead of
template, were performed to confirm lack of contamination with
post-PCR product. PCR products were quantified using the
Quant-iTTM PicoGreenH dsDNA Kit according to the manufac-
turer’s conditions (Turner BioSystems, Inc., Sunnyvale, CA).
Concentration of all obtained PCR products was around 50 ng/
ml and they were thus considered homogeneous. Finally for each
time point, 50 ng of amplicons corresponding to individual
samples were pooled together.
Pooled 16S rRNA gene amplicons were then sequenced using
454 GS FLX Titanium technology (Cogenics, Meylan, France for
the mouse trial and Macrogen, Geumchen-gu, South Korea for
the pig trial). All sequence reads are deposited at the metage-
nomics analysis server MG-RAST (http://metagenomics.anl.gov/,
Project ID 153).
For the mouse trial, pyrosequencing produced an average of
30,840 reads per subject and time point after quality filtering was
applied using the RDP’s Pyrosequencing Pipeline (at http://pyro.
cme.msu.edu/init/form.spr) [39] of no ambiguous bases, exact
primer, and 210 bp reads. Reads were clustered into operational
taxonomic units (OTUs) at a 100% sequence identity threshold
using the RDP’s Pyrosequencing Pipeline [39].
For the pig trial, pyrosequencing produced an average of 29,830
reads per subject and time point after quality filtering was applied
using the Qiime settings [40] of no ambiguous bases, a mean
quality score above 25, a mean window quality score above 25,
maximum homopolymer run not exceeding a limit of 6 and no
mismatches in the primer, and trimming the error-prone 39 ends
at a length of 210 bp. Reads were clustered into operational
taxonomic units (OTUs) at a 97% sequence identity threshold
using Qiime [40].
Clustering analysis was then carried out using UniFrac distance
[41] based PCoAs to provide a deep understanding of the
structures within the datasets. Taxonomic level datasets were
generated by mapping the reads to taxonomic levels using the
RDP classifier [39]. A confidence value of 0.5 was considered a
positive identification. Using these datasets, groups of samples
could be compared at multiple phylogenetic depths. In order to
control for varying number of reads between subjects, the overall
data per subject was normalized by scaling to an intensity of 1.
To assign amplicon sequences to species level, we extracted
77,294 V4 sequences from 127,977 full-length 16S rRNA genes
having complete species classifications (RDP release 10.24) using
the same primer pair as was used for the amplification. In brief, an
association table with species-specific cut-off BLAST scores was
designed from an all-against-all BLAST search of the in silico
extracted V4 sequences. If the same-species score for a certain
species was higher than the score of the first hit against a different
species, than that species was considered assignable, and the score
of the first hit against a different species was recorded as the cut-off
score. Thus, 53% of 9,664 species with extracted V4 sequences
were assignable through this approach. Subsequently, all 9,645
and 271,059 OTUs in the porcine and murine data sets,
respectively, were BLAST searched against this species database
resulting in classification efficiencies of 2.6% and 5.3% for porcine
and murine data sets, respectively, into species level (best BLAST
hit against that species had to greater than its cut-off score).
Statistical analysis
The processed Pyrosequencing datasets, microbial count dataset
and the cytokine dataset were analyzed in R [42]. Feature
selection was carried out using the Wilcoxon Rank-Sum test with
correction for multiple testing using either Bonferroni correction
or q-values where there were a large number of variables being
tested. Q values were generated using the R library q value [43].
When applying statistics, rare taxa were removed using a filter of
20% occupancy. This means that when applying a statistical test to
a dataset, a variable was removed from testing if it contained 80%
or more zeros. For the mouse feeding trail the time-point 0
samples were grouped for the comparisons to the three treatment
groups.
Statistical analysis of the pig growth performance was carried
out as follows: three treatments were tested using twenty four
entire male pigs arranged in eight randomized complete blocks.
Each block consisted of three individual pigs similar in initial
weight and ancestry. The experiment was analyzed using the
General Linear Models (GLM) procedures of SAS (Sas Inst. Inc.,
Cary, NC) for a randomized complete block design. The pig was
the experimental unit and the model used for the statistical analysis
of pig performance had the effects for treatment. The results were
presented as least squares means 6 SEM. The Duncan’s multiple
range procedure was used for means separation.
Alpha diversity in murine and porcine microbiota datasets was
calculated using both Shannon and Phylogenetic Diversity metrics
[44]. The R statistical software was used to generate the statistics
[42]. The Kruskal-Wallis test was used to determine statistical
differences between the groups in the Lactobacillus genus as a whole
and in L. intestinalis. The Mann-Whitney test was used to
determine significant differences between each pair of groups.
Supporting Information
Figure S1 Construction and confirmation of the abpT
gene deletion in L. salivarius UCC118. A) Schematic
representation of the DabpT mutant construction using the
pORI19-pVE6007 system; see Materials and Methods for details.
B) Confirmation of the abpT gene deletion by Southern
hybridization. The 1 kb probe corresponds to the upper-region
of the abpT gene. Expected lengths of genomic fragment
recognized by the probe after digestion with EcoRV are shown.
C) Bacteriocin production phenotype of UCC118 Bac+ and Bac2
strains using an overlay method. Presence of a halo indicates
sensitivity of the indicator strain (L. sakei) to the tested strain and
thus indicates if bacteriocin is produced or not.
(PDF)
Figure S2 Microbiota diversity analysis of mice and
pigs administered with L. salivarius UCC118. Panel A
shows the mean value of two measures of alpha diversity for the six
groups in the murine dataset, and Panel B shows the same
parameters for the six groups in the porcine dataset.. The error
bars are a measure of the standard error of the mean (S.E.M). The
y-axis on the left indicates phylogenetic diversity and the y-axis on
the right indicates the Shannon Index.
(PDF)
Table S1 Bacterial strains and plasmids used in this
study.
(PDF)
Table S2 Primers used in this study.
(PDF)
Table S3 Effect of L. salivarius UCC118 administration
on the murine microbiota composition.
(PDF)
Table S4 Effect of L. salivarius UCC118 administration
on the porcine microbiota composition.
(PDF)
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